Analyst Consensus ?
ConsensusHold34 ratings
Bullish1544.1%
Neutral1750.0%
Bearish25.9%
FN2 Earnings Intelligence
Arch Capital Group Ltd. (ACGL) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 28, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Morgan Stanley | Equal Weight | Overweight | Downgrade | Oct 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Oct 12, 2026 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Oct 12, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Oct 9, 2026 |
| Cantor Fitzgerald | Neutral | Neutral | Maintain | Oct 7, 2026 |
| Mizuho | Neutral | Neutral | Maintain | Sep 16, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Aug 5, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 30, 2026 |
| Roth Capital | Buy | Buy | Maintain | Jul 29, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 29, 2026 |
| UBS | Buy | Buy | Maintain | Jul 8, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 7, 2026 |
| Citigroup | Buy | Buy | Maintain | Apr 30, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jan 8, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Jan 7, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jun 10, 2025 |
| JMP Securities | Market Outperform | Market Outperform | Maintain | Apr 30, 2025 |
| TD Cowen | Buy | Buy | Maintain | Sep 20, 2024 |
| Roth MKM | Buy | Buy | Maintain | Aug 23, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 1, 2024 |
| Wolfe Research | Outperform | Outperform | Maintain | Oct 12, 2021 |
| Credit Suisse | Neutral | Neutral | Maintain | Jan 11, 2021 |
| CFRA | Buy | Buy | Maintain | Feb 12, 2020 |
| MKM Partners | Buy | Buy | Maintain | Oct 30, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Sep 12, 2019 |
| Bank of America | Underperform | Underperform | Maintain | Aug 1, 2018 |
| Keefe Bruyette & Woods | Outperform | Market Perform | Upgrade | Mar 22, 2018 |
| Nomura | Neutral | Neutral | Maintain | Nov 11, 2015 |
| Sterne Agee CRT | Neutral | Neutral | Maintain | Sep 21, 2015 |
| Macquarie | Neutral | Outperform | Downgrade | Apr 15, 2013 |
| Stifel Nicolaus | Hold | Buy | Downgrade | Dec 10, 2012 |
| Stifel | Hold | Buy | Downgrade | Dec 10, 2012 |
| Evercore Partners | Overweight | Overweight | Maintain | Feb 16, 2012 |
Upside is calculated against the persisted current price $101.48. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Bob Huang | $100 | $97.16 | -1.5% | Oct 13, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $105 | $94.82 | +3.5% | Oct 7, 2026 |
| Mizuho Securities | Yaron Kinar | $100 | $97.04 | -1.5% | Sep 16, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $110 | $101.44 | +8.4% | Aug 3, 2026 |
| RBC Capital | Analyst unavailable | $120 | $99.93 | +18.3% | Jul 30, 2026 |
| Atlantic Equities | Analyst unavailable | $126 | $99.14 | +24.2% | Jul 15, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $102 | $102.01 | +0.5% | Jul 9, 2026 |
| Mizuho Securities | Analyst unavailable | $104 | $102.01 | +2.5% | Jul 9, 2026 |
| UBS | Brian Meredith | $120 | $102.35 | +18.3% | Jul 8, 2026 |
| Morgan Stanley | Analyst unavailable | $105 | $94.53 | +3.5% | May 1, 2026 |
| UBS | Brian Meredith | $114 | $99.85 | +12.3% | Feb 17, 2026 |
| Cantor Fitzgerald | Ryan Tunis | $100 | $100.03 | -1.5% | Feb 17, 2026 |
| Mizuho Securities | Yaron Kinar | $102 | $98.61 | +0.5% | Feb 12, 2026 |
| Morgan Stanley | Analyst unavailable | $125 | $90.94 | +23.2% | Jan 16, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $97 | $90.77 | -4.4% | Jan 14, 2026 |
| Barclays | Alex Scott | $104 | $95.16 | +2.5% | Jan 8, 2026 |
| Goldman Sachs | Robert Cox | $93 | $95.16 | -8.4% | Jan 7, 2026 |
| Evercore ISI | David Motemaden | $100 | $94.7 | -1.5% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $95 | $95.72 | -6.4% | Dec 15, 2025 |
| Roth Capital | Analyst unavailable | $110 | $93.16 | +8.4% | Dec 2, 2025 |
| RBC Capital | Analyst unavailable | $108 | $91.94 | +6.4% | Nov 24, 2025 |
| Cantor Fitzgerald | Ryan Tunis | $98 | $85.45 | -3.4% | Oct 28, 2025 |
| Goldman Sachs | Analyst unavailable | $88 | $92.25 | -13.3% | Oct 14, 2025 |
| Barclays | Analyst unavailable | $99 | $94.1 | -2.4% | Oct 8, 2025 |
| Morgan Stanley | Bob Huang | $110 | $95.16 | +8.4% | May 19, 2025 |
| Wells Fargo | Elyse Greenspan | $108 | $89.67 | +6.4% | May 1, 2025 |
| Wells Fargo | Elyse Greenspan | $107 | $92.25 | +5.4% | Jan 14, 2025 |
| Capital One Financial | Michael Zaremski | $104 | $95.78 | +2.5% | Nov 6, 2024 |
| Citigroup | Michael Ward | $114 | $111.73 | +12.3% | Sep 10, 2024 |
| Barclays | Alex Scott | $120 | $113.32 | +18.3% | Sep 4, 2024 |
| Capital One Financial | Michael Zaremski | $98 | $97.68 | -3.4% | Aug 8, 2024 |
| CFRA | Catherine Seifert | $120 | $95.78 | +18.3% | Jul 31, 2024 |
| Evercore ISI | David Motemaden | $104 | $98.83 | +2.5% | Jul 31, 2024 |
| Wells Fargo | Elyse Greenspan | $110 | $93.54 | +8.4% | May 1, 2024 |
| CFRA | Catherine Seifert | $107 | $93.54 | +5.4% | Apr 30, 2024 |
| Deutsche Bank | Cave Montazeri | $110 | $90.59 | +8.4% | Apr 30, 2024 |
| JMP Securities | Matthew Carletti | $110 | $91.25 | +8.4% | Apr 30, 2024 |
| Wells Fargo | Analyst unavailable | $67 | $58.74 | -34.0% | Nov 29, 2022 |
| Morgan Stanley | Analyst unavailable | $56 | $57.62 | -44.8% | Nov 22, 2022 |
| Morgan Stanley | Analyst unavailable | $52 | $47.44 | -48.8% | Aug 19, 2022 |
| Barclays | Analyst unavailable | $52 | $42.7 | -48.8% | Jul 14, 2022 |
| Morgan Stanley | Analyst unavailable | $50 | $45.42 | -50.7% | May 23, 2022 |
| J.P. Morgan | Jimmy Bhullar | $44 | $39.95 | -56.6% | Jul 1, 2021 |
Track every rating change on ACGL the moment it posts. Free to start.
Start freeOne email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.